Clin2
NCT06962657Possibly a fitNot yet recruiting

Coenzyme Q10 for health problems after the East Palestine derailment

Toxicant Induced Chronic Multisymptom Illness and Associated Symptoms and Comorbidities

This study tests whether coenzyme Q10 (a natural supplement) can reduce long-term health problems in people who were exposed to the chemical spill from the East Palestine train derailment. It may help if you are still having symptoms that started or worsened after the derailment.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
20 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You lived within 10 miles of the East Palestine, Ohio train derailment on Feb. 3, 2023, or you were there helping with cleanup or for other reasons and have similar symptoms.
  • You have had symptoms for more than 6 months in at least 3 of these areas: fatigue/sleep, pain, thinking/mood, stomach, breathing, or skin. The symptoms must be more than mild, and at least some must be new or worse since the derailment.
  • You can use the internet on a smartphone or computer to fill out online surveys.
  • You are willing to follow the study steps, including taking the study capsules.
  • You are not planning to move away from the area or have other obstacles that would prevent you from finishing the study.
  • You are not in another clinical trial, and you do not have a health condition (like active cancer or a chronic infection) that would cause confusing symptoms, and CoQ10 is safe for you (no Coumadin).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06515184Recruiting· Phase 3
Coenzyme Q10 for Gulf War illness study

This study tests whether coenzyme Q10 (a natural supplement) can improve symptoms of Gulf War illness, such as fatigue and body pain. It involves taking the supplement or placebo for several months, with regular check-ins via Zoom and a few blood draws at a local lab.

La Jolla, California
NCT07789106Recruiting
CoQ10 for fatigue and strength in GLP-1 users

This study tests whether Coenzyme Q10 (CoQ10) can help reduce fatigue and improve muscle strength in people who are taking GLP-1 medications for weight management. You will be asked to take a daily supplement (CoQ10 or placebo) for a period and track your progress via a smartphone app.

Glasgow
NCT07772336Not yet recruiting
Coenzyme Q10 for resilience in older adults

This study tests whether a daily supplement of Coenzyme Q10 (a natural substance that helps cells produce energy) can improve physical strength and resilience in older adults who show early signs of frailty. It aims to help people stay independent and active as they age.

NCT05422534Recruiting· Phase 3
CoQ10 plus exercise for people with advanced kidney disease

This trial tests whether a supplement called CoQ10, along with supervised exercise, can improve how the body uses energy in people on chronic dialysis. It may help with muscle function and overall health if your heart and dialysis situation are stable enough.

Sacramento, California
NCT07748130Not yet recruiting
CoQ10 for liver fat in mitochondrial diabetes

This study tests whether taking coenzyme Q10 (a natural supplement) can reduce the amount of fat in the liver of people with a specific genetic form of diabetes (mitochondrial diabetes). It aims to see if the supplement can improve liver health and blood sugar control.

Putian, Fujian
NCT07317440Not yet recruiting
Coenzyme Q10 for children with pneumonia

This study tests whether coenzyme Q10, a natural supplement, can help children recover from pneumonia faster. The trial compares the supplement to standard care.

Tanta, Gharbia Governorate

Hear when a new Toxicant Induced Chronic Multisymptom Illness and Associated Symptoms and Comorbidities trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.